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Prostate cancer is the most common non-skin cancer in America, affecting 1 in 6 men (for more 
information visit the Prostate Cancer Foundation website). As with any illness, early detection of the 
disease is important for disease control by therapeutic intervention. A common chromosomal 
rearrangement in prostate cancers involves the fusion of the TMPRSS2 gene to the ERGoncogene, 
both genes located in close proximity on chromosome 21. This genomic alteration results in the 
deletion of intervening genomic sequences and leads to increased ERG expression, disrupting 
androgen receptor signaling to promote disease progression. 
Several fluorescence in situ hybridization (FISH) techniques have been previously developed to 
investigate TRMPRSS2/ERGrearrangements with relatively low resolution. For instance, a dual-color 
FISH assay can detect chromosome changes at the ERG gene but cannot ascertain whether a 
fusion event of ERG to TRMPRSS2 or any other gene has occurred. To overcome this weakness in 
identifying ERG or TRMPRSS2 rearrangements, the Fang Lab at Seattle Cancer Care Alliance and 
Nelson Lab in the Division of Human Biology at the Hutchinson Center developed a FISH assay that 
can detect a variety of TRMPRSS2/ERGrearrangements in prostate cancer cells. 
The researchers developed four color-distinct probes, two of which label the 5’ and 3’ ends of 
the TMPRSS2 gene and the other two label the 5’ and 3’ region of the ERG gene. They used these 
probes to stain normal and prostate cancer cells to analyze the different genomic rearrangements 
that occurred with the TMPRSS2 and ERG genes. In normal cells, all four probes recognize the 
intact chromosome and produce a cluster of four-colored signals. In prostate tumors, a common 
gene fusion event involves the fusion of the 5’ region of TMPRSS2 with the 3’ region of ERG.  The 
intervening chromosomal sequences can become deleted or translocated to a different 
chromosome. Indeed, 50% of the scored prostate tumors showed this 
common TRMPRSS2/ERG fusion, as indicated by the loss of hybridization of two of the probes due 
to chromosomal deletion. The four-colored FISH assay also efficiently detected other less 
common TRMPRSS2/ERG fusions including dual and multiple-deletion fusions (see figure). 
To prove the applicability of their novel FISH assay to detect gene fusions in a variety of cells, the 
researchers stained prostate cell lines, and also primary and metastatic prostate cancer samples. 
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Indeed, the four-color FISH assay revealed the presence of theTRMPRSS2/ERG fusion in ~50% of 
primary and metastatic prostate cancer samples. More importantly, additional and alternative genetic 
rearrangements at the TRMPRSS2 and ERG loci were apparent. These alternative rearrangements 
would have been missed by other FISH-based approaches, highlighting the ability of the FISH 
approach devised by Qu et. al. to detect novel genomic alterations within genes that promote 
prostate cancer progression. The researchers also showed that theTRMPRSS2/ERG fusion status 
identified by their novel FISH assay was consistent with the fusion status defined by two 
complementary approaches: RT-PCR and Gen-Probe. 
In summary, Qu et. al. have generated a robust, analytically sensitive and highly specific assay to 
identify typical and atypicalTRMPRSS2/ERG fusions in prostate cancer cells. This assay will aid in 
the elucidation of the complex genomic alterations that are involved in prostate cancer pathogenesis 
and prognosis. 
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Image modified from the manuscript 
An example of the four-color FISH assay after probe hybridization in a normal (left) 
and prostate tumor cell (right). In the normal cell, all four of the probes (red, yellow, 
green, and blue) exist within close proximity to one another (in two four-colored foci 
corresponding to a diploid nucleus) since the probes recognize a distinct 
chromosomal locus containing two adjacent genes, TRMPRSS2 and ERG. The 
tumor cell on the right has had two deletion-fusion events at the TRMPRSS2 and 
ERG loci, as evidenced by two blue/red dimeric probe signals and the loss of the 
other two-colored signals (lower right side of nucleus). 
 
